Cardiac and Lung Assessment of Professional Soccer Players Following COVID-19 Disease

NCT04871867 | Completed

• 1 other identifier: americanHparis
• Study Type: observational
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

During this world COVID-19 outbreak, and according to the experience of team doctors, after their return, some players could have been affected by the SARS-cov2. Also, this study aims to clearly determine the condition of athletes at the end of lockdown after this COVID-19 crisis and the cardiorespiratory consequences in particular in those who have been affected by COVID-19 and the prevalence of acute myocarditis. The investigators assess in this observational study the cardiac and lung consequences of COVID-19..

Conditions

Covid19

Keywords

COVID19; athletes; cardiac assessment; lung CT-scanner; COVID19 cardiopulmonary consequences

Outcome Measures

Primary Outcomes (3)

• Cardiac abnormalities

  qualitative

  up to ten days following COVID-19 infection

• acute myocarditis occurence

  qualitative

  up to ten days following COVID-19 infection

• COVID19 lung lesions

  qualitative

  up to ten days following COVID-19 infection

Secondary Outcomes (1)

• global occurrence of COVID19

  one year since march 2020

Eligibility Criteria

• Age: 18 Years - 40 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

Since 2020 spring and during this COVID-19 outbreak, the Professional soccer player were assessed about the COVID-19 infection using the clinical tests, swab PCR Test and SARS-Cov2 serology. The athletes having COVID-19 infection were included in cardiac and lung evaluation.

You may qualify if:

• Professional soccer player
• age over 18 years

You may not qualify if:

• recent muscle injury (\< 1 month)
• recent orthopedic surgery (\< 3 months)

Sponsors & Collaborators

• American Hospital of Paris: lead

Study Sites (1)

American Hospital of Paris

Neuilly-sur-Seine, 92200, France

Location

Related Publications (8)

• Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P, Ji W. Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR. Radiology. 2020 Aug;296(2):E115-E117. doi: 10.1148/radiol.2020200432. Epub 2020 Feb 19. No abstract available.

  PMID: 32073353 BACKGROUND

• Toresdahl BG, Asif IM. Coronavirus Disease 2019 (COVID-19): Considerations for the Competitive Athlete. Sports Health. 2020 May/Jun;12(3):221-224. doi: 10.1177/1941738120918876. Epub 2020 Apr 6. No abstract available.

  PMID: 32250193 BACKGROUND

• Eirale C, Bisciotti G, Corsini A, Baudot C, Saillant G, Chalabi H. Medical recommendations for home-confined footballers' training during the COVID-19 pandemic: from evidence to practical application. Biol Sport. 2020 Jun;37(2):203-207. doi: 10.5114/biolsport.2020.94348. Epub 2020 Apr 10.

  PMID: 32508388 BACKGROUND

• Schellhorn P, Klingel K, Burgstahler C. Return to sports after COVID-19 infection. Eur Heart J. 2020 Dec 7;41(46):4382-4384. doi: 10.1093/eurheartj/ehaa448. No abstract available.

  PMID: 32432700 BACKGROUND

• Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol. 2020 May;31(5):1003-1008. doi: 10.1111/jce.14479. Epub 2020 Apr 13.

  PMID: 32270559 BACKGROUND

• Siripanthong B, Nazarian S, Muser D, Deo R, Santangeli P, Khanji MY, Cooper LT Jr, Chahal CAA. Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020 Sep;17(9):1463-1471. doi: 10.1016/j.hrthm.2020.05.001. Epub 2020 May 5.

  PMID: 32387246 BACKGROUND

• Kim JH. Screening Athletes for Myocarditis With Cardiac Magnetic Resonance Imaging After COVID-19 Infection-Lessons From an English Philosopher. JAMA Cardiol. 2021 Aug 1;6(8):950-951. doi: 10.1001/jamacardio.2020.7463. No abstract available.

  PMID: 33443538 BACKGROUND

• Martinez MW, Tucker AM, Bloom OJ, Green G, DiFiori JP, Solomon G, Phelan D, Kim JH, Meeuwisse W, Sills AK, Rowe D, Bogoch II, Smith PT, Baggish AL, Putukian M, Engel DJ. Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening. JAMA Cardiol. 2021 Jul 1;6(7):745-752. doi: 10.1001/jamacardio.2021.0565.

  PMID: 33662103 BACKGROUND

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Gilles BOCCARA, MD, PhD

  Sport and Health unit of American Hospital of Paris

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 3 Weeks
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: principal investigator

Study Record Dates

• First Submitted: May 1, 2021
• First Posted: May 4, 2021
• Study Start: September 1, 2020
• Primary Completion: March 1, 2022
• Study Completion: March 15, 2022
• Last Updated: August 3, 2022

Record last verified: 2022-08

Locations

FR (1)